Editorial Policy and How We Research

This page explains how every guide on Retatrutide360 is researched, written and kept current.

Sources we use

We start with primary sources: peer-reviewed trial publications such as the New England Journal of Medicine and The Lancet, trial registrations on ClinicalTrials.gov, regulator pages from the FDA, EMA and MHRA, and announcements from Eli Lilly. When a point is about the drug class rather than retatrutide itself, we use the prescribing information for approved medicines in that class and say so.

Forums and social media show what people report, and we sometimes describe those reports. We never present them as evidence.

How a guide is written

1. We check what people are searching for and what the pages already ranking for it do and do not answer.
2. We collect the relevant studies and pull every number from the original source.
3. We write in plain English, keep paragraphs short and flag what is unknown.
4. Every guide lists its sources at the end and shows the date it was last updated.

Updates and corrections

Retatrutide is still in Phase 3, so the evidence changes. When new results are published we update the affected guides and the date at the top of each page. If you find an error, email hello@retatrutide360.com and we will correct it and note the change.

Independence

We are not paid by Eli Lilly or by any clinic. Affiliate links, where they appear, never change what a guide says. See our affiliate disclosure.